ImmuCell Corporation Business Acquisition, Transaction Costs
ImmuCell Corporation (ICCC) had Business Acquisition, Transaction Costs of $97.00 thousand as of 2016-09-30, per its 10-K filed 2019-03-22.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts · last filed 2020-03-27
- 2016-09-30: Business Acquisition, Transaction Costs $97.00K.
- 2016-01-04: Business Acquisition, Transaction Costs $97.00K.
| Period end | Business Acquisition, Transaction Costs |
|---|---|
| 2016-09-30 | $97.00K 10-K · filed 2019-03-22 |
| 2016-01-04 | $97.00K 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |